Studies on the mechanism of immunological enhancement of tumor homografts. III. Interaction between humoral isoantibodies and immune lymphoid cells.

No abstract is available for this paper.

• Publication year

  1963

• Venue

  Journal of the National Cancer Institute

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/jnci/30.6.1205PMID 13935882
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Studies on the mechanism of immunological enhancement of tumor homografts. II. Effect of isoantibodies on various tumor cells.

  1963cited by this paper
• Studies on the mechanism of immunological enhancement of tumor homografts. I. Specificity of immunological enhancement.

  1963cited by this paper
• QUANTITATIVE STUDIES OF THE SENSITIVITY OF NORMAL AND NEOPLASTIC MOUSE CELLS TO THE CYTOTOXIC ACTION OF ISOANTIBODIES

  1962cited by this paper
• DEMONSTRATION OF MOUSE ISOANTIGENS AT THE CELLULAR LEVEL BY THE FLUORESCENT ANTIBODY TECHNIQUE

  1961cited by this paper
• ANTIBODY FORMATION

  1961cited by this paper
• DEPRESSION BY ANTIBODY OF THE IMMUNE RESPONSE TO HOMOGRAFTS AND ITS ROLE IN IMMUNOLOGICAL ENHANCEMENT

  1960cited by this paper
• STUDIES ON THE EFFECT OF ISOANTISERUM ON MOUSE SARCOMA CELLS

  1960cited by this paper
• Studies on the mechanism of immunological enhancement of tumor grafts.

  1960cited by this paper
• SYNERGIC ACTION BETWEEN ISOANTIBODY AND IMMUNE CELLS IN GRAFT REJECTION

  1960cited by this paper
• The time of apperance of isoantibodies during the homograft response to mouse tumours.

  1959cited by this paper
• Factors determining homograft destruction and immunological enhancement in mice receiving successive tumor inocula.

  1958cited by this paper

• Histological demonstration of a biphasic acute inflammatory response to subcutaneous transplants of Ehrlich's carcinoma.

  2009cites this paper
• Oral polyethylene glycol's inhibitory effect on the subcutaneous growth of Ehrlich's carcinoma in mice, and on the local inflammatory response to the tumour.

  2009cites this paper
• Immunological enhancement revisited.

  2002cites this paper
• Mode of alloantibody-mediated blockade of allo-sensitization for tumor allograft rejection.

  1989cites this paper
• Effects of passive enhancement on graft and host. Graft adaptation by alloantibody as the mechanism of prolonged skin allograft survival.

  1984cites this paper
• Induction of Immunity and Suppression by Haptenated Self Structures

  1980cites this paper
• ENHANCING ALLOANTIBODY EFFECTIVE DURING SENSITIZATION BUT NOT EFFECTOR PHASE OF SKIN GRAFT REJECTION

  1979cites this paper
• The dominant role of la antibodies in the passive enhancement of H‐2 incompatible skin grafts

  1975cites this paper
• Commentary: Current status of clinical immunotherapy.

  1975cites this paper
• Immune response to a syngeneic mammary adenocarcinoma. III. Development of memory and suppressor functions modulating cellular cytotoxicity.

  1975cites this paper
• Suppression and enhancement of allografted tumour.

  1974cites this paper
• Mechanisms of immunological enhancement.

  1974cites this paper
• Regulation of the immune response. V. Antibody‐mediated inhibition of T and B cell cooperation in the in vitro response to red cell antigens

  1974cites this paper
• Lymphocyte-mediated immune responses in neoplasia.

  1974cites this paper
• Genetic alterations in tumor cells resulting in their escape from the immune response.

  1974cites this paper
• PASSIVE ENHANCEMENT OF RAT RENAL ALLOGRAFTS WITH ONLY PARTIAL COVER OF THE INCOMPATIBLE Ag‐B SPECIFICITIES

  1974cites this paper
• Synergistic cooperation between isoantiserum and immune lymphoid cells: in vitro studies with a syngeneic rat lymphoma.

  1974cites this paper
• Tumor-associated specificity of serum-mediated inhibition of lymphocyte stimulation by autochthonous human tumors.

  1973cites this paper
• [Immunology of malignant melanoma].

  1973cites this paper
• IMMUNOLOGICAL ENHANCEMENT OF MURINE TUMOR ISOGRAFTS MEDIATED BY RNA FROM LYMPHOID ORGANS OF XENOGENEIC IMMUNIZED ANIMALS

  1971cites this paper
• Immunological facilitation, a broadening of the concept of the enhancement phenomenon.

  1971cites this paper
• Tumor-associated immunoglobulins.

  1971cites this paper
• Spontaneous murine mammary adenocarcinoma: model system for evaluation of combined methods of therapy.

  1971cites this paper
• Basic proteins and synthetic polynucleotides as modifiers of immunogenicity of syngeneic tumor cells.

  1971cites this paper
• Immunological enhancement as studied by cell culture techniques.

  1970cites this paper
• Immunologic enhancement induced by antibody fragments.

  1970cites this paper
• RENAL TRANSPLANTATION IN THE INBRED RAT: XIV. Mechanism of the Modified Rejection Produced by Bone Marrow Cell Pretreatment

  1970cites this paper
• Humoral antibody in allograft reactions.

  1970cites this paper
• Specific immunosuppression by minute doses of passive antibody. II. The site of action.

  1970cites this paper
• Dynamics of immunologic enhancement.

  1970cites this paper
• Graft survival and immunological enhancement.

  1969cites this paper
• Transplantation antigens and viral carcinogenesis.

  1969cites this paper
• Immunologic enhancement of tumor xenografts by pepsin-degraded immunoglobulin.

  1969cites this paper
• Studies on serum‐mediated inhibition of cellular immunity to spontaneous mouse mammary tumors

  1969cites this paper
• Cell selection by antigen in the immune response.

  1969cites this paper
• Cellular immunity against tumor antigens.

  1969cites this paper
• [Combined specific immunosuppression].

  1969cites this paper
• GLOBULIN COATING IN VIVO OF EHRLICH'S ASCITES CARCINOMA CELLS

  1968cites this paper
• The role of circulating antibody in the control of antibody synthesis: mechanism for the suppressive effect of passive antibody on active antibody synthesis.

  1968cites this paper
• ROLE OF THE SPLEEN IN PASSIVE IMMUNOLOGICAL ENHANCEMENT

  1968cites this paper
• STUDIES ON HOMOTRANSPLANTABLE LYMPHOMAS IN HAMSTERS: V. THE SIGNIFICANCE OF IMMUNOFLUORESCENT STAINING IN TISSUES FROM TUMOR‐BEARING ANIMALS

  1968cites this paper
• Regulatory effect of antibody on the immune response.

  1968cites this paper
• Prolonged survival of H-2 different skin allografts in mice specifically immunized with lyophilized spleens in Freund's adjuvant.

  1968cites this paper
• Mechanisms and functions of immunologic enhancement.

  1968cites this paper
• ON THE NATURE OF TRANSPLANTATION IMMUNITY IN THE ADENOVIRUS TUMOR SYSTEM

  1967cites this paper
• Immunologic enhancement induced by 7S antibody globulin.

  1967cites this paper
• In vitro studies of immunological responses of lymphoid cells.

  1967cites this paper
• PROGRESS IN EXPERIMENTAL KIDNEY TRANSPLANTATION

  1967cites this paper
• Inhibition of the transplantation immune response.

  1966cites this paper
• [The phenomenon of immunological enhancement: its consequences; its interpretations].

  1966cites this paper
• Reduced sensitivity of F-1 hybrid rats to re-challenge with parental strain spleen cells.

  1966cites this paper
• Immunology of spontaneous mammary carcinomas in mice. V. Acquired tumor resistance and enhancement in strain A mice infected with mammary tumor virus.

  1966cites this paper
• Biologic properties of 19 S and 7 S mouse isoantibodies directed against isoantigens of the H-2 system.

  1966cites this paper
• Tissue-specific antigens.

  1966cites this paper
• The dual effect of antibodies against sex-linked histocompatibility antigen.

  1966cites this paper
• Cytotoxic Isoantibodies and Immunologic Enhancement in Mice.∗

  1966cites this paper
• Tumor antigens.

  1966cites this paper
• Factors influencing the induction of enhancement and resistance to methylcholanthrene-induced tumours in a syngenic system.

  1965cites this paper
• [Immune reactions (spontaneous or due to therapeutic aims) and the development of cancer (general review)].

  1965cites this paper
• Enhancement in hamsters of virus oncogenesis attending vaccination procedures.

  1965cites this paper
• The relation of the immune reaction to cancer.

  1965cites this paper
• BIOLOGICAL AND CLINICAL ASPECTS OF ORGAN TRANSPLANTATION.

  1965cites this paper
• Interaction between tumor and host during progressive neoplastic growth in histoincompatible recipients.

  1965cites this paper
• IMMUNITY AGAINST CANCEROGEN-INDUCED TUMOURS.

  1965cites this paper
• ANTIBODY SYNTHESIS AT THE CELLULAR LEVEL

  1965cites this paper
• A STUDY OF THE BIOLOGICAL EFFECTIVENESS OF ANTIBODIES IN THE DEVELOPMENT AND PREVENTION OF EXPERIMENTAL AUTOIMMUNE ASPERMATOGENESIS.

  1964cites this paper
• ANTIBODY-INDUCED DEPRESSION OF THE IMMUNE RESPONSE: A STUDY OF THE MECHANISM IN VARIOUS IMMUNOLOGICAL SYSTEMS.

  1964cites this paper
• PROLONGED SURVIVAL OF ALLOGENEIC: (HOMOLOGOUS) NORMAL TISSUES IN ANTISERUM‐TREATED RECIPIENTS

  1964cites this paper
• PREVENTION AND SUPPRESSION OF EXPERIMENTAL AUTOIMMUNE ASPERMATOGENESIS IN ADULT GUINEA PIGS.

  1964cites this paper
• THE MECHANISM OF ANTITUMOUR IMMUNITY STUDIED BY MEANS OF TRANSFERS OF IMMUNITY.

  1964cites this paper
• USE OF "IMMUNOLOGICAL ENHANCEMENT" IN THE STUDY OF HISTOCOMPATIBILITY MUTATIONS.

  1964cites this paper
• RELATIONSHIP BETWEEN HOST RANGE AND ISOANTIGENIC PROPERTIES IN DIFFERENT SUBLINES OF THE SAME SARCOMA.

  1963cites this paper